May 2021
Washington, D.C. (May 19, 2021) —Rep. James E. Clyburn, Chairman of the Select Subcommittee on the Coronavirus Crisis, delivered the following opening statement at today's hybrid hearing with Mr. Robert Kramer, President and Chief Executive Officer of Emergent BioSolutions, Inc. (Emergent), and Mr. Fuad El-Hibri, Executive Chairman of Emergent:
Washington, D.C. (May 19, 2021) — Today, Rep. James E. Clyburn, Chairman of the Select Subcommittee on the Coronavirus Crisis, and Rep. Carolyn B.
Washington, D.C. (May 19, 2021)—Today, Rep. Jamie Raskin, Chairman of the Subcommittee on Civil Rights and Civil Liberties, issued the following statement after Cheniere Energy missed a deadline imposed by the Federal Energy Regulatory Commission (FERC) to repair family farms along the Midship Pipeline. Cheniere Energy owns the Midship Pipeline in Oklahoma, which was put into service in April 2020.
Washington, D.C. (May 18, 2021)—Today, Rep. Carolyn B. Maloney, the Chairwoman of the Committee on Oversight and Reform, spoke on the House Floor in favor of H. Res. 275, Condemning the horrific shootings in Atlanta, Georgia, on March 16, 2021, and reaffirming the House of Representative's commitment to combating hate, bigotry, and violence against the Asian-American and Pacific Islander community.
Washington D.C. (May 18, 2021)— Today, Rep. Carolyn B.
Washington D.C. (May 18, 2021)— On Thursday, May 20, 2021, at 9:00 a.m., Rep. Stephen F. Lynch, the Chairman of the Subcommittee on National Security, will hold a hearing to examine President Biden's decision to withdraw all remaining U.S. military forces from Afghanistan by September 11, 2021, and its implications for U.S. national security and the stability of the region.
Washington, D.C. (May 18, 2021)— Today, Rep. Carolyn B. Maloney, Chairwoman of the Committee on Oversight and Reform, Rep. Jerrold Nadler, Chairman of the Committee on the Judiciary, and Rep. David N.
Washington, D.C. (May 18, 2021)—Below is Committee on Oversight and Reform Chairwoman Carolyn B. Maloney's opening statement, as prepared for delivery, for today's full committee hearing examining the pricing and business practices of AbbVie Inc., which sells the anti-inflammatory drug Humira and the cancer drug Imbruvica.
Washington, D.C. (May 18, 2021)—Today, Rep. Carolyn B. Maloney, Chairwoman of the Committee on Oversight and Reform, issued the following statement after releasing a staff report with new documents and details about AbbVie Inc., which sells the anti-inflammatory drug Humira and the cancer drug Imbruvica. AbbVie has repeatedly raised the prices of these two blockbuster drugs:
Washington D.C. (May 17, 2021)—Today, Rep. Carolyn B. Maloney, the Chairwoman of the Committee on Oversight and Reform, and Rep. Bennie G. Thompson, the Chairman of the Committee on Homeland Security, issued the following statement after today's joint staff briefing with Colonial Pipeline: